Volume 7 Issue 4 - International Biopharmaceutical Industry

Current Edition

Volume 7 Issue 4

Polypure Celebrates and Reflects on 25 Years in the Pharmaceutical Industry

Polypure have been at the forefront of developments in the pharmaceutical industry for 25 years, being a driving force for high-quality PEG’s and PEG-derivatives. Ch...

19 December 2024 Volume 7 Issue 4 | Current Features

Continue Reading →

Volume 7 Issue 4

Emerging Pharma vs. Big Pharma: Rethinking CRO Partnerships

In today’s competitive pharmaceutical landscape, outsourcing has become essential to the development and commercialisation of drugs. This is especially true for emer...

19 December 2024 Volume 7 Issue 4 | Current Features

Continue Reading →

Volume 7 Issue 4

Breath Analysis and Cancer: The Future of Early Detection and Personalised Medicine

VOCs and Breath There are many challenges associated with cancer management, including delayed diagnosis, low efficacy of treatment, and heterogeneity of di...

19 December 2024 Volume 7 Issue 4 | Current Features

Continue Reading →

Volume 7 Issue 4

In vitro Models Guiding Strategic Decision-making in Biotherapeutic Development

Scientific advancements and evolving regulatory requirements are continually reshaping the drug development process. Navigating the intricacies and financial challen...

19 December 2024 Volume 7 Issue 4 | Current Features

Continue Reading →

Volume 7 Issue 4

Accelerating Drug Discovery: Integrating In Vivo and In Vitro Testing with C. elegans

The pharmaceutical industry is continually challenged by high attrition rates (> 90 %) as drug candidates progress from discovery, through clinical trials and to ...

19 December 2024 Volume 7 Issue 4 | Current Features

Continue Reading →

Volume 7 Issue 4

Peptide Therapeutics: Unleashing the Power of Precision Medicine

In the dynamic world of drug discovery and development, where the quest for innovative and effective therapies is relentless, peptide therapeutics have emerged as a ...

19 December 2024 Volume 7 Issue 4 | Current Features

Continue Reading →

Volume 7 Issue 4

Advancing Cancer Immunotherapy Research: The Role of Multiplex Immunoassays

Immunotherapy has revolutionised the treatment of cancer. However, while it shows high efficacy against certain tumours, immunotherapy is not effective against all t...

19 December 2024 Volume 7 Issue 4 | Current Features

Continue Reading →

Volume 7 Issue 4

Overcoming Oncology Drug Resistance: Models and Strategies

Cancer is inherently difficult to detect and treat. To add to this complication, some patients develop drug resistance to treatment, leading to tumour recurrence or ...

19 December 2024 Volume 7 Issue 4 | Current Features

Continue Reading →

Volume 7 Issue 4

The Data Revolution in Drug Discovery: How Lab Automation and AI are Reshaping the Future of Medicine

In drug discovery, a technological shift is underway, promising to transform how we develop new medications and advance precision medicine. At the core of this trans...

19 December 2024 Volume 7 Issue 4 | Current Features

Continue Reading →

Volume 7 Issue 4

CRDMOs Redefining Drug Substance Development with Platform Technologies

The development of biopharmaceuticals is expanding at an unprecedented rate, as the industry now comprises around 20 percent of the global pharmaceutical marke...

19 December 2024 Volume 7 Issue 4 | Current Features

Continue Reading →

International Biopharmaceutical Industry

IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.